Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Pfizer Launches Embrex® Vaccine Manual Inovoject®

Published: Thursday, November 15, 2012
Last Updated: Thursday, November 15, 2012
Bookmark and Share
New, compact in ovo device for vaccine manufacturers.

Pfizer Animal Health Global Poultry has launched a new, compact in ovo device aimed at vaccine manufacturers and research institutes.

Embrex® Vaccine Manual Inovoject® (VMI) is the latest addition to the Embrex Vaccine Manufacturing Device (VMD) portfolio which already includes a range of in ovo devices used for the mass production of human influenza vaccines as well as other human and animal health egg-based vaccines.

This small, semi-automated device enables inoculation to be carried out in the laboratory setting, and so is aimed at vaccine manufacturers that require an alternative to high volume production. It could also be used for research and batch testing.

“The device is designed and produced specifically with the vaccine manufacturing environment in mind - for both human and animal health vaccines,” said Product Engineer, Joe Federowicz.

Federowicz continued, “It is only 30 inches wide, and thus can fit through ordinary laboratory doors. It is also fully enclosed so as to prevent dirt build up and other potential sources of contamination.”

According to Director, Gerardo Vera, Embrex VMI is likely to be of particular interest to vaccine manufacturers in Asia and Latin America markets.

“A typical animal health facility could probably install three to five of these machines, and each one would be used for a different vaccine,” Mr Vera said.

“The full-size Embrex Inovoject has been used by human vaccine manufacturers for many years for large scale flu vaccine production. The new Embrex VMI has the same industry-leading quality, features, functionality and reliability that customers have come to expect from the Embrex brand, which has been at the forefront of in ovo technology for 20 years,” said Mr Federowicz.

“We realized the need for an inoculation device which had the same engineering quality as other Embrex VMD products, but which could be installed in a much smaller area and was suited for smaller production runs.

“It took about a year to refine the design and bring it to market because the quality had to be superlative and up to industry standards. But I am really pleased with the result. The finish has to be seen to be believed: with no visible welds and mirror finish surfaces.”

Embrex VMI is available with the same world-class customer service and parts as offered with Pfizer Animal Health’s existing devices in the poultry business.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Immunotherapy Agent Benefits Patients with Drug-Resistant Multiple Myeloma in First Human Trial
Daratumumab proved generally safe in patients, even at the highest doses.
Inciting an Immune Attack On Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
Less May Be More in Slowing Cholera Epidemics
Mathematical model shows more cases may be prevented and more lives saved when using one dose of cholera vaccine instead of recommended two doses.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Flu Remedies Help Combat E. coli Bacteria
Physiologists from the University of Zurich have now discovered why the intestinal bacterium Escherichia coli (E. coli) multiplies heavily and has an inflammatory effect.
'Fountain of Youth' Protein Points to Possible Human Health Benefit
Patients with higher blood levels of growth factor have lower risk of cardiovascular problems.
Lemon Juice and Human Norovirus
Citric acid may prevent the highly contagious norovirus from infecting humans, scientists discovered from the German Cancer Research Center.
Study Backs Flu Vaccinations for Elderly
Brown University researchers found vaccines well matched to the year’s flu strain significantly reduce deaths and hospitalizations compared to when the match is poor, suggesting that vaccination indeed makes a difference.
Inciting an Immune Attack on Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
Protein Found to Play a Key Role in Blocking Pathogen Survival
Calprotectin fends off microbial invaders by limiting access to iron, an important nutrient.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!